DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Senores Pharmaceuticals Limited — Analyst/Investor Meet Para A-XBRL

NSE 27 Aug·27 Aug 2026, 7:19 am

Senores Pharmaceuticals L

Senores Pharmaceuticals Limited has informed stock exchanges about its upcoming meeting with analysts and institutional investors. This announcement signals that the company is preparing to share its latest business updates, operational strategies, and future outlook with the investment community.

For investors, such meetings are a key opportunity to gauge management’s confidence and gather insights into the company's growth trajectory. It helps clarify the firm's direction and can provide a clearer picture of its performance against market expectations.

Investors should watch for details on the company's product pipeline, sales performance, and any guidance provided during the session. This information will be crucial for assessing the stock's potential in the coming quarters.